Objective: To assess medium-term organ impairment in symptomatic individuals following recovery from acute SARS-CoV-2 infection.
Design: Baseline findings from a prospective, observational cohort study.
Setting: Community-based individuals from two UK centres between 1 April and 14 September 2020.